This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Regeneron Pharmaceuticals Inc (REGN)

NASDAQ: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) 636.06M 348.07M 424.36M 750.27M
Operating Gains/Losses 18.86M 33.47M 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -491.42M -62.43M -198.66M -590.09M
(Increase) Decrease in Inventories -111.83M -60.90M -47.96M 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 303.66M 162.24M 136.68M 10.98M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital 608.89M 19.10M -27.97M -41.08M
Other Non-Cash Items 492.75M 355.29M 245.15M 151.13M
Net Cash From Continuing Operations 1.33B 743.16M 583.65M -74.61M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.33B 743.16M 583.65M -74.61M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 327.44M 476.42M 0.00 439.21M
Purchases of Property, Plant & Equipment -677.93M -333.01M -156.32M -49.34M
Acquisitions 0.00 0.00 0.00 0.00
Purchases of Short-Term Investments -557.11M -564.19M 0.00 -470.39M
Other Cash from Investing Activities 0.00 0.00 0.00 -552.00K
Cash Provided by Financing Activities
Net Cash From Investing Activities -907.60M -420.78M -355.45M -81.07M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 206.36M 126.05M 57.39M 63.55M
Repayment of Long-Term Debt -166.47M -221.73M -2.02M -2.20M
Repurchase of Capital Stock -160.54M -267.58M -195.09M -163.30M
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -142.15M 154.00M 216.86M 4.31M
Net Cash From Financing Activities -262.80M -209.27M 77.14M -97.65M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 160.38M 113.11M 305.33M -253.33M
REGN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

REGN Regeneron Pharmaceuticals Inc

Chart of REGN

Analysts Ratings for REGN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 8 7 7
Moderate Buy 2 2 2 2
Hold 10 9 10 7
Moderate Sell 0 0 0 0
Strong Sell 2 2 1 2
GET REGN ANALYST REPORT

REGN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs